FormWeb • cloZAPine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

cloZAPine

cloZAPine

Formulary Psychiatric Drug Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
FazaClo	TABLET, DISINTEGRATING, ORAL	12.5 mg, 25 mg, 100 mg
Clozaril	TABLET, ORAL	25 mg, 100 mg

VIEW MORE Atypical Antipsychotics

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

cloZAPine (FazaClo)

12.5 mg ODT
25 mg ODT
100 mg ODT

cloZAPine (Clozaril)

Half 25 mg tablet oral (Total: 12.5 mg)
25 mg tablet oral
100 mg tablet oral

Automatically interchange cloZAPine orally disintegrating tablets to the regular tablet at the same dose.

Upon clozapine verification CBC w/differential should be obtained (if not already performed). If ANC results <1000 please contact MD. If ANC acceptable redraw in 2 weeks. Follow up to be performed in Sentri-7.

Reviewed: December 12, 2007 (cloZAPine ODT)

Last updated: Jan. 6, 2026

Black Box Warning: cloZAPine: severe neutropenia, myocarditis, seizure risk

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.